Funder
Central Public Research Institutes Basic Funds for Research and Development
Shanghai Aircraft Manufacturing Company
Reference63 articles.
1. L.M. Genaro et al. Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach, Am. J. Transl. Res. 13(12) (2021) (1943-8141/AJTR0138856) 13916-13930.
2. The global burden of IBD: from 2015 to 2025;Kaplan;Nat. Rev. Gastroenterol. Hepatol.,2015
3. Recent advances in the treatment of IBD: Targets, mechanisms and related therapies;Liu;Cytokine Growth Factor Rev.,2023
4. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells;Ivanov;Cell,2006
5. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22;Takatori;J. Exp. Med.,2009